Katrina et al. found that high levels of STAT1 and STAT1 target genes (CXCL9, CXCL10, and CXCL11) are substantially associated with better treatment response in ovarian cancer (Au et al., 2016). The gene discussed is STAT1; the disease is ovarian carcinoma.